Natural polyphenols that display anticancer properties through inhibition of kinase activity

Current Medicinal Chemistry

Volumn 17, Issue 9, 2010, Pages 812-825

  Lamoral Theys, D ^a   Pottier, L ^a   Dufrasne, F ^a   Neve J ^a   Dubois, J ^a   Kornienko, A ^b   Kiss, R ^a   Ingrassia, L ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CARNOSIC ACID; CARNOSOL; COUMARIN DERIVATIVE; CURCUMIN; DELPHINIDIN; DITERPENE; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; FLAVONOLIGNAN; GREEN TEA EXTRACT; ISOFLAVONE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE; POLO LIKE KINASE; POLYPHENOL DERIVATIVE; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; SILIBININ; STILBENE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; TANNIN; TANNIN DERIVATIVE; UNINDEXED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER RESEARCH; DNA DAMAGE; DRUG MECHANISM; DRUG TARGETING; ENZYME INHIBITION; HUMAN; IMMUNOSTIMULATION; METASTASIS; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; FLAVONOIDS; PHENOLS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77950254934     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790712183     Document Type: Review

References (107)

1. Yang, C. S.; Wang, X.; Lu, G.; Picinich, S. C. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer, 2009, 9, 429-439.
2. Bracke, M. E.; Vanhoecke, B. W.; Derycke, L.; Bolca, S.; Possemiers, S.; Heyerick, A.; Stevens, C. V.; De Keukeleire, D.; Depypere, H. T.; Verstraete, W.; Williams, C. A.; McKenna, S. T.; Tomar, S.; Sharma, D.; Prasad, A. K.; DePass, A. L.; Parmar, V. S. Plant polyphenolics as anti-invasive cancer agents. Anticancer Agents Med. Chem., 2008, 8, 171-185.
3. Fresco, P.; Borges, F.; Diniz, C.; Marques, M. P. M. New insights on the anticancer properties of dietary polyphenols. Med. Chem. Rev., 2006, 26, 747-766. (Pubitemid 44735552)
4. De Kok, T. M.; Van Breda, S. G.; Manson, M. M. Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur. J. Nutr., 2008, 47, 51-59.
5. Smyth, L.A.; Collins, I. Measuring and interpreting the selectivity of protein kinase inhibitors. J. Chem. Biol., 2009, 2, 131-151.
6. Lapenna, S.; Giordano, A. cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discov., 2009, 8, 547-566.
7. Eldar-Finkelman, H.; Eisenstein, M. Peptide inhibitors targeting protein kinases. Curr. Pharm. Res., 2009, 15, 2463-2470.
8. Eglen, R.M.; Reisine, T. The current status of drug discovery against the human kinome. Assay Drug Dev. Technol., 2009, 7, 22-43.
9. Hartmann, J.T.; Haap, M.; Kopp, H.G.; Lipp, H.P. Tyrosine kinase inhibitors - A review on pharmacology, metabolism and side effects. Curr. Drug Metab., 2009, 10, 470-481.
10. Garuti, L.; Roberti, M.; Bottegoni, G. Small molecules aurora kinases inhibitors. Curr. Med. Chem., 2009, 16, 1949-1963.
11. Schöffski, P. Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. Oncologist, 2009, 14, 559-570.
12. Gonelli, A., Mischiati, C.; Guerrini, R.; Voltan, R.; Salvadori, S.; Zauli, G. Perspectives of protein kinase C (PKC) inhibitors as anticancer agents. Mini Rev. Med. Chem., 2009, 9, 498-509.
13. Mahmmoud, Y.A. Modulation of protein kinase C by Curcumin; inhibition and activation switched by calcium ions. Br. J. Pharmacol., 2007, 150, 200-208.
14. Leiro, J.; Alvarez, E.; Garcia, D.; Orallo, F. Resveratrol modulates rat macrophage functions. Int. Immunopharmacol., 2002, 2, 767-774. (Pubitemid 34603121)
15. Stewart, J.R.; Christman, K.L.; O'Brian, C.A. Effects of resveratrol on the autophosphorylation of phorbol ester-responsive protein kinases: inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation. Biochem. Pharmacol., 2000, 60, 1355-1359.
16. Lamoral-Theys, D.; Dufrasne, F.; Van Antwerpen, P.; Pottier, L.; Megalizzi, V.; Lamkami, T.; Le Calve, B.; Gelbcke, M.; Neve, J.; Kiss, R.; Dubois, J. New polyol vanilloyl esters with anti-tumor effects. In: Proceedings of the 100th Annual Meeting of the American Association for Cancer Research. Abstract nr 2687. Denver, Philadelphia, Apr. 18-22, 2009, (epub ahead of print).
17. Fiuza, S. M.; Gomes, C.; Teixeira, L. G. ; Girao da Cruz, M. T.; Cordeiro, M. N.; Milhazes, N.; Borges, F.; Marques, M. P. M. Phe nolic acid derivatives with potential anticancer properties-a structure- activity relationship study. Part 1: Methyl, propyl and octyl esters of caffeic and gallic acids. Bioorg. Med. Chem., 2004, 12, 3581-3589.
18. Park, J. B.; Schoene, N. N-Caffeoyltyramine arrests growth of U937 and Jurkat cells by inhibiting protein tyrosine phosphorylation and inducing caspase-3. Cancer Lett., 2003, 202, 161-171. (Pubitemid 37485889)
19. Kim, Y. M.; Hwang, J. T.; Kwak, D. W.; Lee, Y. K.; Park, O. J. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann. N. Y. Acad. Sci., 2007, 1095, 496-503.
20. Pyun, B. J.; Choi, S.; Lee, Y.; Kim, T. W.; Min, J. K.; Kim, Y.; Kim, B. D.; Kim, J. H.; Kim, T. Y.; Kim, Y. M.; Kwon, Y. G. Capsiate, a nunpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Cancer Res., 2008, 68, 227-235.
21. Bode, A. M.; Ma, W. Y.; Surh, Y. J.; Dong, Z. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-Gingerol. Cancer Res., 2001, 61, 850-853. (Pubitemid 32174390)
22. Lee, S. H.; Cekanova, M.; Baek, S. J. Multiple mechanisms are involved in 6-Gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Mol. Carcinog., 2008, 47, 197-208.
23. Virgili, F.; Sinibaldi, P.; Nardini, M.; Canali, R.; Fimiani, A.; DeLorenzo, A. Superoxide radical anion production is inhibited by tyrosol and p-coumaric acid in human neutrophils: specific effect on protein kinase C activity. Res. Comm. Biochem. Cell Mol. Biol., 1999, 3, 95-104.
24. Kip1 and with induction of differentiation in HL60 cells. J. Nutr., 2008, 138, 42-48.
25. Scheckel, K. A.; Degner, S. C.; Romagnolo, D. Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines. J. Nutr., 2008, 138, 2098-2105.
26. Shahanas, C.; Faisal, T.; Sehamuddin, G. Curcumin cell signalling: a possible target for chemotherapy. Curr. Trends Biotech. Pharm., 2008, 2, 226-238.
27. ΚB signaling. J. Cancer Mol., 2008, 4, 11-16.
28. http://dtp.nci.nih.gov/.
29. Calcabrini, A.; Garcia-Martinez, J. M.; Gonzales, L.; Tendero, J. M.; Ortuno, M. T. A.; Crateri, P.; Lopez-Rivas, A.; Arancia, G.; Gonzales-Porqué, P.; Martin-Perez, J. Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate. Carcinogenesis, 2006, 27, 1699-1712. (Pubitemid 44288060)
30. Yip, E. C. H.; Chan, A. S. L.; Pang, H.; Tam, Y. K.; Wong, Y. H. Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism. Cell Biol. Toxicol., 2006, 22, 293-302.
31. Lin, H. S.; Chen, J. H.; Huang, C. C.; Wang, C. J. Apoptotic effect of 3,4-dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation. Int. J. Cancer, 2007, 120, 2306-2316. (Pubitemid 46642115)
32. Yasukawa, K.; Dimitrijevic, S. M.; Evans, F. J.; Kawabata, S.; Takido, M. Inhibitory effect of Pruni cortex extract and its component, octacosyl ferulate, on tumour promotion by 12-O-tetradecanoylphorbol- 13-acetate in two-stage carcinogenesis in mouse skin. Phytoter. Res., 1998, 12, 261-265. (Pubitemid 28331460)
33. Kang, N. J.; Lee, K. W.; Shin, B. J.; Jung, S. K.; Hwang, M. K.; Bode, A. M.; Heo, Y. S.; Lee, H. J.; Dong, Z. Caffeic acid, a phenolic phytochemical in coffe, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression. Carcinogenesis, 2009, 30, 321-330.
34. Sanchez, A. M.; Sanchez, M. G.; Malagarie-Cazenave, S.; Olea, N.; Diaz-Laviada, I. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Apoptosis, 2006, 11, 89-99. (Pubitemid 43151647)
35. Zhang, R.; Humphreys, I.; Sahu, R. P.; Shi, Y.; Srivastava, S. K. In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis, 2008, 13, 1465-1478.
36. Kim, E. C.; Min, J. K.; Kim, T. Y.; Lee, S. J.; Yang, H. O.; Han, S.; Kim, Y. M.; Kwon, Y. G. [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo. Biochem. Biophys. Res. Commun., 2005, 335, 300-308. (Pubitemid 41140221)
37. Balasubramanian, S.; Eckert, R. L. Keratinocyte proliferation, differentiation, and apoptosis-Differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol. Appl. Pharm., 2007, 224, 214-219.
38. Beevers, C. S.; Chen, L.; Liu, L.; Luo, Y.; Webster, N. J. G. Curcumin disrupts the mammalian target of rapamycin-raptor complex. Cancer Res., 2009, 69, 1000-1008.
39. Kuttan, G.; Kumar, K. B.; Guruvayoorappan, C.; Kuttan, R. Antitumor, anti-invasion, and antimetastatic effects of curcumin. Adv. Exp. Med. Biol., 2007, 595, 173-184.
40. Kundu, J. K.; Surh, Y. J. Cancer chemopreventive and therapeutical potential of resveratrol: mechanistic perspectives. Cancer Lett., 2008, 269, 243-261.
41. Chang, C. J.; Ashendel, C. L.; Geahlen, R. L.; Mclaughlin, J. L.; Waters, D. J. Oncogene signal transduction inhibitors from medicinal plants. In vivo, 1996, 10, 185-190. (Pubitemid 26001182)
42. Pan, M. H.; Chang, Y. H.; Badmaev, V.; Nagabhushanam, K.; Ho, C. T. Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells. J. Agric. Food Chem., 2007, 55, 7777-7785. (Pubitemid 47522187)
43. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov., 2006, 5, 493-506.
44. Priego, S.; Feddi, F.; Ferrer, P.; Mena, S.; Benlloch, M.; Ortega, A.; Carretero, J.; Obrador, E.; Asensi, M.; Estrela J. M. Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism. Mol. Cancer Ther., 2008; 7, 3330-3342.
45. Roberti, M.; Pizzirani, D.; Simoni, D.; Rondanin, R.; Baruchello, R.; Bonora, C.; Buscemi, F.; Grimaudo, S.; Tolomeo, M. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J. Med. Chem., 2003, 46, 3546-3554. (Pubitemid 36909831)
46. Chao, J. I.; Su, W. C.; Liu, H. F. Baicalein induces cancer cell death and proliferation retardation by inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and Akt. Mol. Cancer Ther., 2007, 6, 3039-3048.
47. Lin, Y.; Shi, R.; Wang, X.; Shen, H. M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. Cancer Drug Targets, 2008, 8, 634-649.
48. Singh, S.; Malik, B. K.; Sharma, D. K. Protein kinase C in prostate cancer and herbal products: a bioinformatics approach. Int. J. Integrat. Biol., 2007, 1, 72-87.
49. Kim, J. E.; Kwon, J. Y.; Lee, D. E.; Kang, N. J.; Heo, Y. S.; Lee, K. W.; Lee, H. J. MKK4 is a novel target for the inhibition of tumor necrosis factor-α-induced vascular endothelial growth factor expression by myricetin. Biochem. Pharmacol., 2009, 77, 412-421.
50. Nguyen, T. T. T.; Tran, E.; Ong, C. K.; Lee, S. K.; Do, T .T.; Huynh, T. T.; Nguyen, T. H.; Lee, J. J.; Tan, Y.; Ong, C. S.; Huynh, H. Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J. Cell. Physiol., 2003, 197, 110-121. (Pubitemid 37486233)
51. Weyant, M. J.; Carothers, A. M.; Dannenberg, A. J.; Bertagnolli, M. M. (+)-Catechin inhibits intestinal tumor formation and suppresses focal adhesion kinase activation in the Min/+ Mouse. Cancer Res., 2001, 61, 118-125.
52. Khan, N.; Afaq, F.; Saleem, M.; Ahmad, N.; Mukhtar, H. Targeting multiple signalling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res., 2006, 66, 2500-2505.
53. Siddiqui, I. A.; Adhami, V. M.; Afaq, F.; Ahmad, N. ; Mukhtar, H. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J. Cell. Biochem., 2003, 91, 232-242.
54. Bektic, J.; Guggenberger, R.; Eder, I. E.; Pelzer, A. E.; Berger, A. P.; Bartsch, G.; Klocker, H. Molecular effects of the isoflavonoid genistein in prostate cancer. Clin. Prostate Cancer, 2005, 4, 124-129. (Pubitemid 41474608)
55. Eto, I. Nutritional and chemopreventive anti-cancer agents upregulate expression of p27KipI, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells. Cancer Cell Int., 2006, 6:20.
56. Zi, X.; Agarwal, R. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention. Proc. Natl. Acad. Sci. USA, 1999, 96, 7490-7495. (Pubitemid 29299689)
57. Deep, G.; Singh, R. P.; Agarwal, C.; Kroll, D. J.; Agarwal, R. Silymarin and Silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavonone silibinin with flavonolignan mixture silymarin. Oncogene, 2009, 25, 1053-1069.
58. Singh, R. P.; Raina, K.; Deep, G.; Chan, D.; Agarwal, R. Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signalling. Clin. Cancer Res., 2009, 15, 613-621.
59. Bonham, M.; Posakony, J.; Coleman, I.; Montgomery, B.; Simon, J.; Nelson, P. S. Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin. Cancer Res., 2005, 11, 3905-3914.
60. Lee, K. W.; Kang, N. J.; Heo, Y. S.; Rogozin, E. A.; Pugiliese, A.; Hwang, M. K.; Bowden, G. T.; Bode, A. M.; Lee, H. J.; Dong, Z. Raf and MEK Protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res., 2008, 68, 946-955.
61. Chen, C; Yu, R.; Owuor, E. D.; Kong, A. D. Activation of antioxidant response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res., 2000, 23, 605-612.
62. Hou, Z.; Lambert, J. D.; Chin, K. V.; Yang, C. S. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mut. Res., 2004, 555, 3-19.
63. Sah, J. F.; Balasubramanian, S.; Eckert, R. L.; Rorke, E. A. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. J. Biol. Chem., 2004, 279, 12755-12762.
64. Thangapazham, R. L.; Singh, A. K.; Sharma, A.; Warren, J.; Gaddipati, J. P.; Maheshwari, R. K. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett., 2007, 245, 232-241.
65. Liao, S.; Umekita, Y.; Guo, J.; Kokontis, J. M.; Hiipakka, R. A. Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett., 1995, 96, 239-243.
66. Bain, J.; McLauchlan, H.; Elliott, M.; Cohen, P. The specificities of protein kinase inhibitors: an update. Biochem. J., 2003, 371, 199-204. (Pubitemid 36458094)
67. Way, T. D.; Lee, H. H.; Kao, M. C.; Lin, J. K. Black tea polyphenol theaflavins inhibits aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression. Eur. J. Cancer, 2004, 40, 2165-2174.
68. Liang, Y. C.; Chen, Y. C.; Lin, Y. L.; Lin-Shiau, S. Y.; Ho, C. T.; Lin, J. K. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate. Carcinogenesis, 1999, 20, 733-736.
69. Choi, E. J.; Kim, G. H. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Phytomedecine, 2008, 15, 683-690.
70. Su, S. J.; Chow, N. H.; Kung, M. L.; Hung, T. C.; Chang, K. L. Effects on soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr. Cancer, 2003, 45, 113-123.
71. Scholar, E. M.; Toews, M. L.; Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett., 1994, 87, 159-162.
72. Banerjee, S.; Li, Y.; Wang, Z.; Sarkar, F. H. Multi-targeted therapy of cancer by genistein. Cancer Lett., 2008, 269, 226-242.
73. Singh, R. P.; Gu, M.; Agarwal, R. Silibinin Inhibits Colorectal Cancer Growth by Inhibiting Tumor Cell Proliferation and Angiogenesis. Cancer Res., 2008, 68, 2043-2050. (Pubitemid 351416592)
74. Singh, R. P.; Deep, G.; Blouin, M. J.; Pollak, M. N.; Agarwal, R. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft. Carcinogenesis, 2007, 28, 2567-2574. (Pubitemid 350238960)
75. Davis-Searles, P. R.; Nakanishi, Y.; Kim, N. C.; Graf, T. N.; Oberlies, §N. H.; Wani, M. C.; Wall, M. E.; Agarwal, R.; Kroll, D. J. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res., 2005, 65, 4448-4457.
76. Stoker, J. R.; Bellis, D. M. The biosynthesis of coumarin in Melitus Alba. J. Biol. Chem., 1962, 237, 2303-2305.
77. Lacy, A.; O'Kennedy, R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr. Pharm. Design, 2004, 10, 3797-3811. (Pubitemid 39409871)
78. Park, C.; Jin, C. Y.; Kim, G. Y.; Choi, I. W.; Kwon, T. K.; Choi, B. T.; Lee, W. H.; Choi, Y. H. Induction of apoptosis by Esculetin in human leukemia U937 cells through activation of JNK and ERK. Toxicol. Appl. Pharm., 2008, 227, 219-228. (Pubitemid 351231936)
79. Manuele, G. M.; Ferraro, G.; Arcos, M. L. B.; Lopez, P.; Cremaschi, G.; Anesini, C. Comparative immunomodulatory effect of scopoletin on tumoral and normal lymphocytes. Life Sci., 2006, 79, 2043-2048. (Pubitemid 44528585)
80. Yang, E. B.; Zhao, Y. N. ; Zhang, K. ; Mack, P. Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor. Biochem. Biophys. Res. Commun., 1999, 260, 682-685.
81. Kuo, M. L.; Wu, W. S.; Lee, C.; Lin, J. K. Effects of tannic acid on 12-Otetradecanoylphorbol-13-acetate-induced protein kinase C activation in the NIH 3T3 cells. Biochem. Pharmacol., 1993, 46, 1327-1332. (Pubitemid 23319300)
82. Galati, G.; O'Brien, P. J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med., 2004, 37, 287-303.
83. Kong, J. M.; Chia, L. S.; Goh, N. K.; Chia, T. F., Brouillard, R. Analysis and biological activities of anthocyanins. Phytochemistry, 2003, 64, 923-933.
84. Meiers, S.; Kemény, M.; Weyand, U.; Gastpar, R.; Von Angerer, E.; Marko, D. The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor. J. Agric. Food Chem., 2001, 49, 958-962. (Pubitemid 32172654)
85. Hwang, M. K.; Kang, N. J.; Heo, Y. S.; Lee, K. W.; Lee, H. J. Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha. Biochem. Pharmacol., 2009, 77, 1213-1222.
86. Kwon, J. Y.; Lee, K. W.; Hur, H. J.; Lee, H. J. Peonidin inhibits phorbol-ester-induced COX-2 expression and transformation in JB6 P+ cells by blocking phosphorylation of ERK-1 and -2. Ann. N. Y. Acad. Sci., 2007, 1095, 513-520.
87. Johnson, J. J.; Syed, D. N.; Heren, C. R.; Suh, Y.; Adhami, V. M.; Mukhtar, H. Carnosol, a dietary diterpene, display growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5′-AMP-activated protein kinase (AMPK) pathway. Pharm. Res., 2008, 25, 2125-2134.
88. Szaefer, H.; Kaczmarek, J.; Rybczynska, M.; Baer-Dubowska, W. The effect of plant phenols on the expression and activity of phorbol ester-induced PKC in mouse epidermis. Toxicology, 2007, 230, 1-10. (Pubitemid 46073325)
89. Yang, E. B.; Wei, L.; Zhang, K.; Chen, Y. Z.; Chen, W. N. Tannic acid, a potent inhibitor of epidermal growth factor receptor tyrosine kinase. J. Biochem., 2006, 139, 495-502. (Pubitemid 43667113)
90. Marienfeld, C.; Tadlock, L.; Yamagiwa, Y.; Patel, T. Inhibition of cholangiocarcinoma growth by tannic acid. Hepatology, 2003, 37, 1097-1104. (Pubitemid 36538686)
91. Martin, S.; Favot, L.; Matz, R.; Lugnier, C.; Andriantsitihaina, R. Delphinidin inhibits endothelial cell proliferation and cell cycle progression through a transient activation of ERK-1/-2. Biochem. Pharmacol., 2003, 65, 669-675.
92. Huang, S. C.; Ho, C. T.; Lin-Shiau, S. Y.; Lin, J. K. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factorkappaB and c-Jun. Biochem. Pharmacol., 2005, 69, 221-232.
93. Singletary, K.; MacDonald, C.; Wallig, M. Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett., 1996, 104, 43-48. (Pubitemid 126334309)
94. Steiner, M.; Preil, I.; Giat, J.; Levy, J. ; Sharoni, Y. ; Danilenko, M. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Nutr. Cancer, 2004, 41, 135-144. (Pubitemid 34666233)
95. Reuter, S.; Eifes, S.; Dicato, M.; Aggarwal, B.B.; Diederich, M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem. Pharmacol., 2008, 76, 1340-1351.
96. Wilson, M.A.; Rimando, A.M.; Wolkow, C.A. Methoxylation enhances stilbene bioactivity in Caenorhabditis elegans. BMC Pharmacol., 2008, 8, 15 .
97. Perecko, T.; Jancinova, V.; Drabikova, K.; Nosal, R.; Harmatha, J. Structure-efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene. Neuro Endocrinol. Lett., 2008, 29, 802-805.
98. Pan, Z.; Agawal, A.K.; Xu, T.; Feng, Q.; Baerson, S.R.; Duke, S.O.; Rimando, A.M. Identification of molecular pathways affected by pterostilbene, a natural dimethylether analog of resveratrol. BMC Med. Genom., 2008, 1, 7.
99. Pan, M.H.; Chiou, Y.S.; Chen, W.J.; Wang, J.M.; Badmaev, V.; Ho, C.T. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Carcinogenesis, 2009, 30, 1234-1242.
100. Bain, J.; Plater, L.; Elliott, M.; Shpiro, N.; Hastie, C. J.; McLauchlan, H.; Klevernic, I. ; Arthur, J. S. C. ; Alessi, D. R.; Cohen, P. The selectivity of protein kinase inhibitors: a further update. Biochem. J., 2007, 408, 297-315.
101. Koo, K. A.; Kim, N. D.; Chon, Y. S.; Jung, M. S.; Lee, B. J.; Kim, J. H.; Song, W. J. QSAR analysis of pyrazolidine-3,5-diones derivatives as Dyrk1A inhibitors. Bioorg. Med. Chem. Lett., 2009, 19, 2324-2328.
102. Bouchikhi, F.; Anizon, F.; Moreau, P. Synthesis, kinase inhibitory potencies and in vitro antiproliferative activity of isoindigo and 7′-azaisoindigo derivatives substituted by Sonogashira cross-coupling. Eur. J. Med. Chem., 2009, 44, 2705-2710.
103. Akue-Gedu, R.; Debiton, E.; Ferandin, Y.; Meijer, L.; Prudhomme, M.; Anizon, F.; Moreau, P. Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins. Bioorg. Med. Chem., 2009, 17, 4420-4424.
104. Crean, S.; Boyd, D.M.; Sercus, B.; Lahn, M. Safety of multitargeted kinase inhibitors as monotherapy treatment of cancer: a systematic review of the literature. Curr. Drug Saf., 2009, 4, 143-154.
105. Glade, M.J. Food, nutrition, and the prevention of cancer: a global perspective. American Institute of Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition, 1999, 15, 523-526.
106. Siddiiqui, M. A. A.; Scott, L. J. Imatinib - a review of its use in the management of gastrointestinal stromal tumors. Drugs 2007, 67, 805-820. (Pubitemid 46535650)
107. Vogt, P. K.; Kang, S. Kinase inhibitors: vice becomes virtue. Cancer Cell, 2006, 9, 327-328. (Pubitemid 43668736)